BRIDGEBIO PHARMA INC - NOTE 2.250% 2/0

Q1 2023 Portfolio Holders as of 3/31/2023

Type / Class
Debt / NOTE 2.250% 2/0
Number of holders
40
Total Principal
465 M
Shares change
-19.7 M
Total reported value, excl. options
$323 M
Value change
-$7.13 B
Put/Call ratio
0
Number of buys
17
Number of sells
-18
Price
$0.64
CUSIP
10806XAD4
Investor Option Weight % Change % Value $ * Price $ Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.